---
schema_version: "secwatch.filing_event.v1"
accession: "0001552781-24-000405"
form_type: "8-K"
ticker: "SWKHL"
cik: "0001089907"
company_name: "SWK Holdings Corp"
filed_at: "2024-07-19T23:59:59+00:00"
generated_at: "2026-05-31T18:56:02.262381+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# SWK Holdings names new CFO, repurchases $1M in stock, provides portfolio updates

## Summary
- Adam Rice, CPA, joined as CFO in July; Courtney Baker promoted to Controller.
- Repurchased 58,567 shares for $1.0M in Q2; YTD through July 15 bought 197,969 shares for $3.4M.
- Funded $2.0M term loan to AOTI in May; Journey Medical drew $5.0M additional term loan in June.
- Journey Medical can draw incremental $5.0M upon FDA approval of DFD-29 (PDUFA Nov 4, 2024).
- Portfolio companies AOTI, Biolase, Biotricity, Elutia, Eton, Journey, Shield reported progress.

## SEC filing metadata
- accession: 0001552781-24-000405
- form_type: 8-K
- ticker: SWKHL
- cik: 0001089907
- company_name: SWK Holdings Corp
- filed_at: 2024-07-19T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1089907/000155278124000405/0001552781-24-000405-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1089907/000155278124000405/e24312_swkh-8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001552781-24-000405
- JSON: https://secwatch.observer/filing/0001552781-24-000405.json
- Plain text: https://secwatch.observer/filing/0001552781-24-000405.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.